Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

Trump-era Limit on Nursing Homes Safety Fines Is Lifted

As the Delta variant raises fresh concerns about the safety of the nation’s nursing homes, the Biden administration has quietly reversed a controversial Trump policy…

View More Trump-era Limit on Nursing Homes Safety Fines Is Lifted

F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine

The database indicates only one possible death of a recipient of the Johnson & Johnson shot from Guillain-Barré syndrome. But the man, a 57-year-old from…

View More F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine

Juul Is Fighting to Keep Its E-Cigarettes on the U.S. Market

Sales have plunged by $500 million. The work force has been cut by three-quarters. Operations in 14 countries have been abandoned. Many state and local…

View More Juul Is Fighting to Keep Its E-Cigarettes on the U.S. Market

Stress and Burnout Still Plague Front-Line Health Care Workers as Pandemic Eases

The interactions she has with Covid patients, many of them African American, often leave her shaken. She recalled a recent exchange with a woman in…

View More Stress and Burnout Still Plague Front-Line Health Care Workers as Pandemic Eases

Juul Settles N.C. Vaping Case, Agrees to Pay $40 Million

Juul has agreed to pay North Carolina $40 million to settle the first of a spate of lawsuits brought by states that claimed the company’s…

View More Juul Settles N.C. Vaping Case, Agrees to Pay $40 Million

Helping Drug Users Survive, Not Abstain: ‘Harm Reduction’ Gains Federal Support

GREENSBORO, N.C. — The thin young man quietly took in the room as he waited for the free supplies meant to help him avoid dying:…

View More Helping Drug Users Survive, Not Abstain: ‘Harm Reduction’ Gains Federal Support

Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited

Dr. Salloway, a site principal investigator for trials of the drug, wasn’t paid for that work but has received research and consulting fees from Biogen.…

View More Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited
Top